Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Acute Respiratory Distress Syndrome”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)UnknownNCT05947747
What this trial is testing

Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

Who this might be right for
ARDS
Nano24med 90
Not applicableStudy completedNCT02606240
What this trial is testing

Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

Who this might be right for
Acute Respiratory Distress Syndrome
Groupe Hospitalier Pitie-Salpetriere 20
Not applicableUnknownNCT04619667
What this trial is testing

Effects of a New Interface for NIV on Respiratory Drive

Who this might be right for
Acute Respiratory Failure
University Magna Graecia 22
Not applicableStudy completedNCT02570217
What this trial is testing

HHHFNC (Heated Humidified High-Flow Nasal Cannula) Versus NCPAP for Respiratory Distress Syndrome of Prematurity

Who this might be right for
Newborn Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 316
Not applicableUnknownNCT03156218
What this trial is testing

The Effect of FiO2 on PaO2/FiO2 Ratio

Who this might be right for
PaO2/FiO2 Ratio
Amsterdam UMC, location VUmc 20
Early research (Phase 1)Not Yet RecruitingNCT05983627
What this trial is testing

Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress Syndrome
Asia Cell Therapeutics (Shanghai) Co., Ltd. 9
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT03235986
What this trial is testing

InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)

Who this might be right for
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici S.p.A. 166
Testing effectiveness (Phase 2)Ended earlyNCT04305457
What this trial is testing

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Who this might be right for
Coronavirus InfectionsPneumonia, ViralAcute Respiratory Distress Syndrome
Massachusetts General Hospital 62
Early research (Phase 1)Looking for participantsNCT07449572
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
HTIC, Inc 24
Testing effectiveness (Phase 2)Study completedNCT04402060
What this trial is testing

APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Who this might be right for
COVIDCovid-19Coronavirus+6 more
Apellis Pharmaceuticals, Inc. 72
Not applicableUnknownNCT04619641
What this trial is testing

Physiological Effects of a New Interface on Lung Ventilation and Gas Distribution

Who this might be right for
Acute Respiratory Failure
University Magna Graecia 15
Not applicableStudy completedNCT04617093
What this trial is testing

Post-Market Study of Low-flow ECCO2R Using PrismaLung+

Who this might be right for
Mild to Moderate Acute Respiratory Distress Syndrome
Vantive Health LLC 63
Testing effectiveness (Phase 2)WithdrawnNCT05212662
What this trial is testing

Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

Who this might be right for
COVID-19COVID-19 Acute Respiratory Distress Syndrome
Thiogenesis Therapeutics, Inc.
Not applicableUnknownNCT05056090
What this trial is testing

Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.

Who this might be right for
ARDSAcute Respiratory Distress SyndromeIntensive Care Unit+1 more
University Hospital, Grenoble 656